Select Publications
Conference Posters
2022, 'PD-0325 Feasibility and safety of MR-guided stereotactic ablative body radiotherapy for Prostate Cancer', Vol. 170, pp. S288 - S289, http://dx.doi.org/10.1016/s0167-8140(22)02818-3
,2022, 'PD-0334 Feasibility of magnetic resonance-guided stereotactic ablative body radiotherapy of liver cancer', Vol. 170, pp. S298 - S299, http://dx.doi.org/10.1016/s0167-8140(22)02827-4
,2022, 'PO-1037 Patterns of care and acute toxicity of MR-Linac: Initial results from the first 1000 fractions', Vol. 170, pp. S872 - S873, http://dx.doi.org/10.1016/s0167-8140(22)03001-8
,2022, 'PO-1064 A Registry for Analysis of Data to Advance Personalised Therapy with MR-Linac (ADAPT-MRL)', Vol. 170, pp. S899 - S900, http://dx.doi.org/10.1016/s0167-8140(22)03028-6
,2022, 'PO-1374 Feasibility of magnetic resonance-guided adaptive post-prostatectomy radiotherapy', Vol. 170, pp. S1166 - S1167, http://dx.doi.org/10.1016/s0167-8140(22)03338-2
,2020, 'PO-0799: Target delineation uncertainties using MRI for H&N cancer patients', Vol. 152, pp. S434 - S434, http://dx.doi.org/10.1016/s0167-8140(21)00816-1
,2013, 'NON-SMALL CELL LUNG CANCER (NSCLC): CHANGES IN VOLUME DURING RADIOTHERAPY AND POTENTIAL ADAPTIVE RADIOTHERAPY PLANNING', Vol. 8, pp. S844 - S845, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339624904080&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,